About Lenacapavir
            
            Class: | Antiretroviral agent (capsid inhibitor)  
Use: | Treatment of HIV-1 infection in adults and pediatric patients (age 12 years and older) as part of a complete regimen  
Adult dose: | 300 mg administered subcutaneously once every 6 months after an initial loading dose of 600 mg (given as two 300 mg injections)  
Pediatric dose: | Not established for patients under 12 years; dosing for patients aged 12 years and older is the same as adults  
Side effects: | Injection site reactions, nausea
         
        
            
                
                
                    
                        Drug Class
                    
                    Antiretroviral agent (capsid inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of HIV-1 infection in adults and pediatric patients (age 12 years and older) as part of a complete regimen
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from light; do not freeze
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Gilead Sciences INC., United States of America
                    
                    
                    Package Size
                    5's {5' Blister x 1)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 19117.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        300 mg administered subcutaneously once every 6 months after an initial loading dose of 600 mg (given as two 300 mg injections)
                    
                    
                        Pediatric Dose
                    
                    
                        Not established for patients under 12 years; dosing for patients aged 12 years and older is the same as adults
                    
                 
                
                
                    
                        Side Effects
                    
                    Injection site reactions, nausea, fatigue, headache, diarrhea, and potential for hypersensitivity reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to lenacapavir or any component of the formulation; caution in patients with a history of severe allergic reactions
         
        
        
            
                Important Warnings
            
            Risk of developing resistance if used as monotherapy; monitor for signs of hypersensitivity; not recommended for use in patients with active hepatitis B or C without appropriate management
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.